ID   RTEL1_HUMAN             Reviewed;        1219 AA.
AC   Q9NZ71; A2A397; A2A398; B4DRM5; B4DYM3; B4E3N6; E1P5J4; E1P5J5; Q5JTV3;
AC   Q5JTV4; Q9BW37; Q9H402; Q9H4X6; Q9NX25; Q9NZ73; Q9UPR4; Q9Y4R6;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   28-JUN-2023, entry version 184.
DE   RecName: Full=Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065};
DE            EC=3.6.4.12 {ECO:0000255|HAMAP-Rule:MF_03065};
DE   AltName: Full=Novel helicase-like;
GN   Name=RTEL1 {ECO:0000255|HAMAP-Rule:MF_03065};
GN   Synonyms=C20orf41, KIAA1088, NHL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND
RP   AMPLIFICATION IN GASTRIC TUMORS.
RX   PubMed=10655513; DOI=10.1073/pnas.97.3.1230;
RA   Bai C., Connolly B., Metzker M.L., Hilliard C.A., Liu X., Sandig V.,
RA   Soderman A., Galloway S.M., Liu Q., Austin C.P., Caskey C.T.;
RT   "Overexpression of M68/DcR3 in human gastrointestinal tract tumors
RT   independent of gene amplification and its location in a four-gene
RT   cluster.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1230-1235(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT HIS-1042.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   SEQUENCE REVISION TO 291-292.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (FEB-2012) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5; 7; 8 AND 9), AND
RP   VARIANTS THR-929 AND HIS-1042.
RC   TISSUE=Colon carcinoma, Teratocarcinoma, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING
RP   (ISOFORMS 2; 5 AND 6).
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 708-1219 (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF LYS-48.
RX   PubMed=18957201; DOI=10.1016/j.cell.2008.08.016;
RA   Barber L.J., Youds J.L., Ward J.D., McIlwraith M.J., O'Neil N.J.,
RA   Petalcorin M.I.R., Martin J.S., Collis S.J., Cantor S.B., Auclair M.,
RA   Tissenbaum H., West S.C., Rose A.M., Boulton S.J.;
RT   "RTEL1 maintains genomic stability by suppressing homologous
RT   recombination.";
RL   Cell 135:261-271(2008).
RN   [10]
RP   INTERACTION WITH MMS19.
RX   PubMed=22678361; DOI=10.1126/science.1219664;
RA   Gari K., Leon Ortiz A.M., Borel V., Flynn H., Skehel J.M., Boulton S.J.;
RT   "MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism.";
RL   Science 337:243-245(2012).
RN   [11]
RP   FUNCTION, VARIANTS DKCB5 LYS-251; ILE-492; ARG-710; VAL-739; GLU-897;
RP   TRP-957 AND LEU-964, VARIANT DKCB5 HIS-509 (ISOFORM 5), AND VARIANT DKCB5
RP   HIS-1264 (ISOFORMS 1 AND 6).
RX   PubMed=23453664; DOI=10.1016/j.ajhg.2013.02.001;
RA   Walne A.J., Vulliamy T., Kirwan M., Plagnol V., Dokal I.;
RT   "Constitutional mutations in RTEL1 cause severe dyskeratosis congenita.";
RL   Am. J. Hum. Genet. 92:448-453(2013).
RN   [12]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MMS19.
RX   PubMed=23585563; DOI=10.1074/jbc.m112.416602;
RA   Seki M., Takeda Y., Iwai K., Tanaka K.;
RT   "IOP1 protein is an external component of the human cytosolic iron-sulfur
RT   cluster assembly (CIA) machinery and functions in the MMS19 protein-
RT   dependent CIA pathway.";
RL   J. Biol. Chem. 288:16680-16689(2013).
RN   [13]
RP   INTERACTION WITH TERF1, AND VARIANT DKCB5 ILE-492.
RX   PubMed=23959892; DOI=10.1073/pnas.1300600110;
RA   Deng Z., Glousker G., Molczan A., Fox A.J., Lamm N., Dheekollu J.,
RA   Weizman O.E., Schertzer M., Wang Z., Vladimirova O., Schug J., Aker M.,
RA   Londono-Vallejo A., Kaestner K.H., Lieberman P.M., Tzfati Y.;
RT   "Inherited mutations in the helicase RTEL1 cause telomere dysfunction and
RT   Hoyeraal-Hreidarsson syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:E3408-E3416(2013).
RN   [14]
RP   INVOLVEMENT IN PFBMFT3, AND VARIANTS PFBMFT3 LEU-484; LEU-647 AND PRO-1124.
RX   PubMed=25848748; DOI=10.1038/ng.3278;
RA   Stuart B.D., Choi J., Zaidi S., Xing C., Holohan B., Chen R., Choi M.,
RA   Dharwadkar P., Torres F., Girod C.E., Weissler J., Fitzgerald J.,
RA   Kershaw C., Klesney-Tait J., Mageto Y., Shay J.W., Ji W., Bilguvar K.,
RA   Mane S., Lifton R.P., Garcia C.K.;
RT   "Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary
RT   fibrosis and telomere shortening.";
RL   Nat. Genet. 47:512-517(2015).
RN   [15]
RP   VARIANT DKCB5 ASP-591, VARIANT DKCA4 THR-621, AND VARIANTS SER-124;
RP   GLN-684; PRO-829; ASP-849; THR-929; HIS-1034; HIS-1042 AND THR-1059.
RX   PubMed=23329068; DOI=10.1007/s00439-013-1265-8;
RA   Ballew B.J., Yeager M., Jacobs K., Giri N., Boland J., Burdett L.,
RA   Alter B.P., Savage S.A.;
RT   "Germline mutations of regulator of telomere elongation helicase 1, RTEL1,
RT   in dyskeratosis congenita.";
RL   Hum. Genet. 132:473-480(2013).
RN   [16]
RP   VARIANTS DKCB5 MET-699 AND MET-745, VARIANT DKCB5 ARG-489 (ISOFORM 5), AND
RP   VARIANT DKCB5 ARG-1244 (ISOFORMS 1 AND 6).
RX   PubMed=23591994; DOI=10.1093/hmg/ddt178;
RA   Le Guen T., Jullien L., Touzot F., Schertzer M., Gaillard L.,
RA   Perderiset M., Carpentier W., Nitschke P., Picard C., Couillault G.,
RA   Soulier J., Fischer A., Callebaut I., Jabado N., Londono-Vallejo A.,
RA   de Villartay J.P., Revy P.;
RT   "Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short
RT   telomeres and genome instability.";
RL   Hum. Mol. Genet. 22:3239-3249(2013).
RN   [17]
RP   VARIANTS DKCB5 HIS-509 (ISOFORM 5) AND HIS-1264 (ISOFORMS 1 AND 6),
RP   FUNCTION, AND CHARACTERIZATION OF VARIANTS DKCB5 HIS-509 (ISOFORM 5) AND
RP   HIS-1264 (ISOFORMS 1 AND 6).
RX   PubMed=24009516; DOI=10.1371/journal.pgen.1003695;
RA   Ballew B.J., Joseph V., De S., Sarek G., Vannier J.B., Stracker T.,
RA   Schrader K.A., Small T.N., O'Reilly R., Manschreck C.,
RA   Harlan Fleischut M.M., Zhang L., Sullivan J., Stratton K., Yeager M.,
RA   Jacobs K., Giri N., Alter B.P., Boland J., Burdett L., Offit K.,
RA   Boulton S.J., Savage S.A., Petrini J.H.;
RT   "A recessive founder mutation in regulator of telomere elongation helicase
RT   1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal
RT   Hreidarsson syndrome.";
RL   PLoS Genet. 9:E1003695-E1003695(2013).
CC   -!- FUNCTION: ATP-dependent DNA helicase implicated in telomere-length
CC       regulation, DNA repair and the maintenance of genomic stability. Acts
CC       as an anti-recombinase to counteract toxic recombination and limit
CC       crossover during meiosis. Regulates meiotic recombination and crossover
CC       homeostasis by physically dissociating strand invasion events and
CC       thereby promotes noncrossover repair by meiotic synthesis dependent
CC       strand annealing (SDSA) as well as disassembly of D loop recombination
CC       intermediates. Also disassembles T loops and prevents telomere
CC       fragility by counteracting telomeric G4-DNA structures, which together
CC       ensure the dynamics and stability of the telomere. {ECO:0000255|HAMAP-
CC       Rule:MF_03065, ECO:0000269|PubMed:18957201,
CC       ECO:0000269|PubMed:23453664, ECO:0000269|PubMed:24009516}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03065};
CC   -!- SUBUNIT: Interacts with TERF1. Interacts (via PIP-box) with PCNA; the
CC       interaction is direct and essential for suppressing telomere fragility.
CC       Interacts with MMS19; the interaction mediates the association of RTEL1
CC       with the cytosolic iron-sulfur protein assembly (CIA) complex.
CC       {ECO:0000255|HAMAP-Rule:MF_03065, ECO:0000269|PubMed:22678361,
CC       ECO:0000269|PubMed:23585563, ECO:0000269|PubMed:23959892}.
CC   -!- INTERACTION:
CC       Q9NZ71; Q96T76: MMS19; NbExp=4; IntAct=EBI-2859587, EBI-1044169;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03065,
CC       ECO:0000269|PubMed:23585563}. Note=Colocalizes with PCNA within the
CC       replication foci in S-phase cells. {ECO:0000255|HAMAP-Rule:MF_03065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2;
CC         IsoId=Q9NZ71-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q9NZ71-2; Sequence=VSP_036940;
CC       Name=4;
CC         IsoId=Q9NZ71-4; Sequence=VSP_007076, VSP_007077;
CC       Name=5;
CC         IsoId=Q9NZ71-5; Sequence=VSP_017093, VSP_017094;
CC       Name=6;
CC         IsoId=Q9NZ71-6; Sequence=VSP_017094;
CC       Name=7;
CC         IsoId=Q9NZ71-7; Sequence=VSP_036938;
CC       Name=8;
CC         IsoId=Q9NZ71-8; Sequence=VSP_036939;
CC       Name=9;
CC         IsoId=Q9NZ71-9; Sequence=VSP_036937;
CC   -!- DOMAIN: The PIP-box (PCNA interacting peptide) motif mediates the
CC       interaction with PCNA and localization to replication foci.
CC       {ECO:0000255|HAMAP-Rule:MF_03065}.
CC   -!- DISEASE: Dyskeratosis congenita, autosomal recessive, 5 (DKCB5)
CC       [MIM:615190]: A form of dyskeratosis congenita, a rare multisystem
CC       disorder caused by defective telomere maintenance. It is characterized
CC       by progressive bone marrow failure, and the clinical triad of
CC       reticulated skin hyperpigmentation, nail dystrophy, and mucosal
CC       leukoplakia. Common but variable features include premature graying,
CC       aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and
CC       liver fibrosis among others. Early mortality is often associated with
CC       bone marrow failure, infections, fatal pulmonary complications, or
CC       malignancy. DKCB5 is characterized by onset of bone marrow failure and
CC       immunodeficiency in early childhood. Most patients also have growth and
CC       developmental delay and cerebellar hypoplasia, consistent with a
CC       clinical diagnosis of Hoyeraal-Hreidarsson syndrome.
CC       {ECO:0000269|PubMed:23329068, ECO:0000269|PubMed:23453664,
CC       ECO:0000269|PubMed:23591994, ECO:0000269|PubMed:23959892,
CC       ECO:0000269|PubMed:24009516}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry. RTEL1 mutations have also
CC       been found in patients with a dyskeratosis congenita-like phenotype
CC       consisting of one feature of dyskeratosis congenita and short
CC       telomeres, in the absence of the typical DKC diagnostic triad
CC       (PubMed:23329068). {ECO:0000269|PubMed:23329068}.
CC   -!- DISEASE: Dyskeratosis congenita, autosomal dominant, 4 (DKCA4)
CC       [MIM:615190]: A rare multisystem disorder caused by defective telomere
CC       maintenance. It is characterized by progressive bone marrow failure,
CC       and the clinical triad of reticulated skin hyperpigmentation, nail
CC       dystrophy, and mucosal leukoplakia. Common but variable features
CC       include premature graying, aplastic anemia, low platelets,
CC       osteoporosis, pulmonary fibrosis, and liver fibrosis among others.
CC       Early mortality is often associated with bone marrow failure,
CC       infections, fatal pulmonary complications, or malignancy.
CC       {ECO:0000269|PubMed:23329068}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Pulmonary fibrosis, and/or bone marrow failure, telomere-
CC       related, 3 (PFBMFT3) [MIM:616373]: An autosomal dominant disease
CC       associated with shortened telomeres. Pulmonary fibrosis is the most
CC       common manifestation. Other manifestations include aplastic anemia due
CC       to bone marrow failure, hepatic fibrosis, and increased cancer risk,
CC       particularly myelodysplastic syndrome and acute myeloid leukemia.
CC       Phenotype, age at onset, and severity are determined by telomere
CC       length. {ECO:0000269|PubMed:25848748}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Amplified in gastric tumors.
CC   -!- MISCELLANEOUS: [Isoform 1]: Variant in position: 1264:R->H (in DKCB5),
CC       abolishes activity. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the helicase family. RAD3/XPD subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03065}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF217795; AAF33687.1; -; mRNA.
DR   EMBL; AF217796; AAF35243.1; -; Genomic_DNA.
DR   EMBL; AB029011; BAA83040.3; -; mRNA.
DR   EMBL; AK000485; BAA91197.1; -; mRNA.
DR   EMBL; AK302508; BAG63785.1; -; mRNA.
DR   EMBL; AK299332; BAG61337.1; -; mRNA.
DR   EMBL; AK304798; BAG65548.1; -; mRNA.
DR   EMBL; AL353715; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75238.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75239.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75240.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75241.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75245.1; -; Genomic_DNA.
DR   EMBL; AL080127; CAB45725.1; -; mRNA.
DR   CCDS; CCDS13530.3; -. [Q9NZ71-7]
DR   CCDS; CCDS13531.1; -. [Q9NZ71-1]
DR   CCDS; CCDS63331.1; -. [Q9NZ71-6]
DR   CCDS; CCDS74751.1; -. [Q9NZ71-9]
DR   PIR; T12516; T12516.
DR   PIR; T45294; T45294.
DR   RefSeq; NP_001269938.1; NM_001283009.1. [Q9NZ71-6]
DR   RefSeq; NP_001269939.1; NM_001283010.1. [Q9NZ71-9]
DR   RefSeq; NP_057518.1; NM_016434.3. [Q9NZ71-1]
DR   RefSeq; NP_116575.3; NM_032957.4. [Q9NZ71-7]
DR   AlphaFoldDB; Q9NZ71; -.
DR   SMR; Q9NZ71; -.
DR   BioGRID; 119711; 104.
DR   IntAct; Q9NZ71; 30.
DR   STRING; 9606.ENSP00000353332; -.
DR   iPTMnet; Q9NZ71; -.
DR   PhosphoSitePlus; Q9NZ71; -.
DR   BioMuta; RTEL1; -.
DR   DMDM; 229462743; -.
DR   EPD; Q9NZ71; -.
DR   jPOST; Q9NZ71; -.
DR   MassIVE; Q9NZ71; -.
DR   MaxQB; Q9NZ71; -.
DR   PaxDb; Q9NZ71; -.
DR   PeptideAtlas; Q9NZ71; -.
DR   ProteomicsDB; 83330; -. [Q9NZ71-1]
DR   ProteomicsDB; 83331; -. [Q9NZ71-2]
DR   ProteomicsDB; 83332; -. [Q9NZ71-4]
DR   ProteomicsDB; 83333; -. [Q9NZ71-5]
DR   ProteomicsDB; 83334; -. [Q9NZ71-6]
DR   ProteomicsDB; 83335; -. [Q9NZ71-7]
DR   ProteomicsDB; 83336; -. [Q9NZ71-8]
DR   ProteomicsDB; 83337; -. [Q9NZ71-9]
DR   Antibodypedia; 58405; 162 antibodies from 25 providers.
DR   DNASU; 51750; -.
DR   Ensembl; ENST00000318100.9; ENSP00000322287.5; ENSG00000258366.12. [Q9NZ71-9]
DR   Ensembl; ENST00000360203.11; ENSP00000353332.5; ENSG00000258366.12. [Q9NZ71-6]
DR   Ensembl; ENST00000370018.7; ENSP00000359035.3; ENSG00000258366.12. [Q9NZ71-1]
DR   Ensembl; ENST00000482936.6; ENSP00000457868.2; ENSG00000258366.12. [Q9NZ71-8]
DR   Ensembl; ENST00000508582.7; ENSP00000424307.2; ENSG00000258366.12. [Q9NZ71-7]
DR   GeneID; 51750; -.
DR   KEGG; hsa:51750; -.
DR   MANE-Select; ENST00000360203.11; ENSP00000353332.5; NM_001283009.2; NP_001269938.1. [Q9NZ71-6]
DR   UCSC; uc002yfu.3; human. [Q9NZ71-1]
DR   AGR; HGNC:15888; -.
DR   CTD; 51750; -.
DR   DisGeNET; 51750; -.
DR   GeneCards; RTEL1; -.
DR   GeneReviews; RTEL1; -.
DR   HGNC; HGNC:15888; RTEL1.
DR   HPA; ENSG00000258366; Low tissue specificity.
DR   MalaCards; RTEL1; -.
DR   MIM; 608833; gene.
DR   MIM; 615190; phenotype.
DR   MIM; 616373; phenotype.
DR   neXtProt; NX_Q9NZ71; -.
DR   OpenTargets; ENSG00000258366; -.
DR   Orphanet; 1775; Dyskeratosis congenita.
DR   Orphanet; 3322; Hoyeraal-Hreidarsson syndrome.
DR   Orphanet; 2032; Idiopathic pulmonary fibrosis.
DR   PharmGKB; PA134915625; -.
DR   VEuPathDB; HostDB:ENSG00000258366; -.
DR   eggNOG; KOG1132; Eukaryota.
DR   GeneTree; ENSGT00950000182970; -.
DR   HOGENOM; CLU_006515_4_0_1; -.
DR   InParanoid; Q9NZ71; -.
DR   OMA; TERSEDF; -.
DR   OrthoDB; 124793at2759; -.
DR   PhylomeDB; Q9NZ71; -.
DR   PathwayCommons; Q9NZ71; -.
DR   Reactome; R-HSA-171319; Telomere Extension By Telomerase.
DR   Reactome; R-HSA-2564830; Cytosolic iron-sulfur cluster assembly.
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   SignaLink; Q9NZ71; -.
DR   BioGRID-ORCS; 51750; 457 hits in 1160 CRISPR screens.
DR   GenomeRNAi; 51750; -.
DR   Pharos; Q9NZ71; Tbio.
DR   PRO; PR:Q9NZ71; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9NZ71; protein.
DR   Bgee; ENSG00000258366; Expressed in sural nerve and 93 other tissues.
DR   ExpressionAtlas; Q9NZ71; baseline and differential.
DR   Genevisible; Q9NZ71; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISS:BHF-UCL.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IMP:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003678; F:DNA helicase activity; IMP:UniProtKB.
DR   GO; GO:0070182; F:DNA polymerase binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0032508; P:DNA duplex unwinding; ISS:BHF-UCL.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-UniRule.
DR   GO; GO:1902990; P:mitotic telomere maintenance via semi-conservative replication; ISS:BHF-UCL.
DR   GO; GO:0045910; P:negative regulation of DNA recombination; ISS:BHF-UCL.
DR   GO; GO:1904430; P:negative regulation of t-circle formation; IMP:BHF-UCL.
DR   GO; GO:1904506; P:negative regulation of telomere maintenance in response to DNA damage; ISS:BHF-UCL.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IMP:BHF-UCL.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; ISS:BHF-UCL.
DR   GO; GO:1904358; P:positive regulation of telomere maintenance via telomere lengthening; IMP:BHF-UCL.
DR   GO; GO:1904535; P:positive regulation of telomeric loop disassembly; ISS:BHF-UCL.
DR   GO; GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0031297; P:replication fork processing; ISS:BHF-UCL.
DR   GO; GO:0000732; P:strand displacement; ISS:BHF-UCL.
DR   GO; GO:0000723; P:telomere maintenance; IMP:UniProtKB.
DR   GO; GO:0043247; P:telomere maintenance in response to DNA damage; ISS:BHF-UCL.
DR   GO; GO:0090657; P:telomeric loop disassembly; IMP:BHF-UCL.
DR   CDD; cd17970; DEAHc_FancJ; 1.
DR   CDD; cd13932; HN_RTEL1; 2.
DR   CDD; cd18788; SF2_C_XPD; 1.
DR   Gene3D; 1.20.1160.20; -; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   HAMAP; MF_03065; RTEL1; 1.
DR   InterPro; IPR006555; ATP-dep_Helicase_C.
DR   InterPro; IPR010614; DEAD_2.
DR   InterPro; IPR045028; DinG/Rad3-like.
DR   InterPro; IPR014013; Helic_SF1/SF2_ATP-bd_DinG/Rad3.
DR   InterPro; IPR006554; Helicase-like_DEXD_c2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR013020; Rad3/Chl1-like.
DR   InterPro; IPR030845; RTEL1.
DR   PANTHER; PTHR11472; DNA REPAIR DEAD HELICASE RAD3/XP-D SUBFAMILY MEMBER; 1.
DR   PANTHER; PTHR11472:SF62; REGULATOR OF TELOMERE ELONGATION HELICASE 1; 1.
DR   Pfam; PF06733; DEAD_2; 1.
DR   Pfam; PF13307; Helicase_C_2; 1.
DR   SMART; SM00488; DEXDc2; 1.
DR   SMART; SM00491; HELICc2; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS51193; HELICASE_ATP_BIND_2; 1.
DR   TIGRFAMs; TIGR00604; rad3; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Alternative splicing; ATP-binding; Disease variant; DNA damage;
KW   DNA repair; DNA-binding; Dyskeratosis congenita; Helicase; Hydrolase; Iron;
KW   Iron-sulfur; Metal-binding; Nucleotide-binding; Nucleus;
KW   Reference proteome.
FT   CHAIN           1..1219
FT                   /note="Regulator of telomere elongation helicase 1"
FT                   /id="PRO_0000101985"
FT   DOMAIN          7..296
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   REGION          287..306
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          757..786
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          839..877
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          979..1005
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1017..1054
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1132..1151
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1159..1219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           151..167
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   MOTIF           250..253
FT                   /note="DEAH box"
FT   MOTIF           871..877
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   MOTIF           1178..1185
FT                   /note="PIP-box"
FT   COMPBIAS        848..862
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1170..1186
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         42..49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305"
FT   BINDING         145
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   BINDING         163
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   BINDING         172
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   BINDING         207
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03065"
FT   VAR_SEQ         1..755
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_017093"
FT   VAR_SEQ         1..223
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036937"
FT   VAR_SEQ         131
FT                   /note="Y -> YRSRCRATLWVLETAPPRPTVLSPT (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036938"
FT   VAR_SEQ         998..1219
FT                   /note="GRTAPDPKLTVSTAAAQQLDPQEHLNQGRPHLSPRPPPTGDPGSQPQWGSGV
FT                   PRAGKQGQHAVSAYLADARRALGSAGCSQLLAALTAYKQDDDLDKVLAVLAALTTAKPE
FT                   DFPLLHRFSMFVRPHHKQRFSQTCTDLTGRPYPGMEPPGPQEERLAVPPVLTHRAPQPG
FT                   PSRSEKTGKTQSKISSFLRQRPAGTVGAGGEDAGPSQSSGPPHGPAASEWGL -> ERR
FT                   RIPS (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036939"
FT   VAR_SEQ         999..1023
FT                   /note="RTAPDPKLTVSTAAAQQLDPQEHLN -> NFPDALDQLCGSTSLHQEERRRI
FT                   PS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_007076"
FT   VAR_SEQ         1024..1219
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_007077"
FT   VAR_SEQ         1219
FT                   /note="L -> EPHGRDIAGQQATGAPGGPLSAGCVCQGCGAEDVVPFQCPACDFQRC
FT                   QACWQRHLQASRMCPACHTASRKQSVMQVFWPEPHKDHEGAGGARPVAAVPGVGAACPA
FT                   AGAGCTRSGRNTHLPLAGRRDRGAAGVCPVPPRHLCAAAVPPRQPHDVWPVSTAPLHAV
FT                   LELPGALPLLQRPLRGA (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:10470851,
FT                   ECO:0000303|PubMed:10655513"
FT                   /id="VSP_036940"
FT   VAR_SEQ         1219
FT                   /note="L -> EPHGRDIAGQQATGAPGGPLSAGCVCQGCGAEDVVPFQCPACDFQRC
FT                   QACWQRHLQASRMCPACHTASRKQSVMQVFWPEPQ (in isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_017094"
FT   VARIANT         124
FT                   /note="N -> S (in dbSNP:rs3848668)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_054970"
FT   VARIANT         251
FT                   /note="E -> K (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123019)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069714"
FT   VARIANT         484
FT                   /note="P -> L (in PFBMFT3; dbSNP:rs786205700)"
FT                   /evidence="ECO:0000269|PubMed:25848748"
FT                   /id="VAR_073795"
FT   VARIANT         492
FT                   /note="M -> I (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs370343781)"
FT                   /evidence="ECO:0000269|PubMed:23453664,
FT                   ECO:0000269|PubMed:23959892"
FT                   /id="VAR_069715"
FT   VARIANT         591
FT                   /note="E -> D (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123051)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069716"
FT   VARIANT         621
FT                   /note="A -> T (in DKCA4; dbSNP:rs398123052)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069717"
FT   VARIANT         647
FT                   /note="P -> L (in PFBMFT3; dbSNP:rs1177091623)"
FT                   /evidence="ECO:0000269|PubMed:25848748"
FT                   /id="VAR_073796"
FT   VARIANT         684
FT                   /note="R -> Q (in dbSNP:rs35640778)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069718"
FT   VARIANT         699
FT                   /note="I -> M (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123048)"
FT                   /evidence="ECO:0000269|PubMed:23591994"
FT                   /id="VAR_069719"
FT   VARIANT         710
FT                   /note="L -> R (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069720"
FT   VARIANT         739
FT                   /note="G -> V (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123016)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069721"
FT   VARIANT         745
FT                   /note="V -> M (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123049)"
FT                   /evidence="ECO:0000269|PubMed:23591994"
FT                   /id="VAR_069722"
FT   VARIANT         829
FT                   /note="Q -> P"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069723"
FT   VARIANT         849
FT                   /note="G -> D (in dbSNP:rs190887884)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069724"
FT   VARIANT         897
FT                   /note="K -> E (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069725"
FT   VARIANT         929
FT                   /note="A -> T (in dbSNP:rs61736615)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069726"
FT   VARIANT         957
FT                   /note="R -> W (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs398123018)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069727"
FT   VARIANT         964
FT                   /note="F -> L (in DKCB5; severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs1470145133)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_069728"
FT   VARIANT         1034
FT                   /note="P -> H (in dbSNP:rs115610405)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069729"
FT   VARIANT         1042
FT                   /note="Q -> H (in dbSNP:rs3208008)"
FT                   /evidence="ECO:0000269|PubMed:10470851,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:23329068"
FT                   /id="VAR_054971"
FT   VARIANT         1059
FT                   /note="A -> T (in dbSNP:rs115303435)"
FT                   /evidence="ECO:0000269|PubMed:23329068"
FT                   /id="VAR_069730"
FT   VARIANT         1124
FT                   /note="H -> P (in PFBMFT3; dbSNP:rs786205702)"
FT                   /evidence="ECO:0000269|PubMed:25848748"
FT                   /id="VAR_073797"
FT   MUTAGEN         48
FT                   /note="K->R: Abolishes ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:18957201"
FT   CONFLICT        41
FT                   /note="E -> G (in Ref. 5; BAG63785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        48
FT                   /note="K -> R (in Ref. 5; BAG61337)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        845
FT                   /note="A -> V (in Ref. 5; BAG63785)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        986
FT                   /note="R -> Q (in Ref. 5; BAG61337)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         Q9NZ71-2:1244
FT                   /note="C -> R (in DKCB5, severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome)"
FT                   /evidence="ECO:0000269|PubMed:23591994"
FT                   /id="VAR_082827"
FT   CONFLICT        Q9NZ71-2:1352
FT                   /note="C -> R (in Ref. 2; BAA83040)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         Q9NZ71-5:489
FT                   /note="C -> R (in DKCB5, severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome)"
FT                   /evidence="ECO:0000269|PubMed:23591994"
FT                   /id="VAR_082828"
FT   VARIANT         Q9NZ71-5:509
FT                   /note="R -> H (in DKCB5, abolishes activity)"
FT                   /evidence="ECO:0000269|PubMed:23453664,
FT                   ECO:0000269|PubMed:24009516"
FT                   /id="VAR_082829"
FT   VARIANT         Q9NZ71-6:1244
FT                   /note="C -> R (in DKCB5, severe form consistent with
FT                   Hoyeraal-Hreidarsson syndrome; dbSNP:rs587777037)"
FT                   /evidence="ECO:0000269|PubMed:23591994"
FT                   /id="VAR_082830"
FT   VARIANT         Q9NZ71-6:1264
FT                   /note="R -> H (in DKCB5, abolishes activity;
FT                   dbSNP:rs201540674)"
FT                   /evidence="ECO:0000269|PubMed:23453664"
FT                   /id="VAR_082831"
SQ   SEQUENCE   1219 AA;  133683 MW;  28DFCFCC48BC0055 CRC64;
     MPKIVLNGVT VDFPFQPYKC QQEYMTKVLE CLQQKVNGIL ESPTGTGKTL CLLCTTLAWR
     EHLRDGISAR KIAERAQGEL FPDRALSSWG NAAAAAGDPI ACYTDIPKII YASRTHSQLT
     QVINELRNTS YRPKVCVLGS REQLCIHPEV KKQESNHLQI HLCRKKVASR SCHFYNNVEE
     KSLEQELASP ILDIEDLVKS GSKHRVCPYY LSRNLKQQAD IIFMPYNYLL DAKSRRAHNI
     DLKGTVVIFD EAHNVEKMCE ESASFDLTPH DLASGLDVID QVLEEQTKAA QQGEPHPEFS
     ADSPSPGLNM ELEDIAKLKM ILLRLEGAID AVELPGDDSG VTKPGSYIFE LFAEAQITFQ
     TKGCILDSLD QIIQHLAGRA GVFTNTAGLQ KLADIIQIVF SVDPSEGSPG SPAGLGALQS
     YKVHIHPDAG HRRTAQRSDA WSTTAARKRG KVLSYWCFSP GHSMHELVRQ GVRSLILTSG
     TLAPVSSFAL EMQIPFPVCL ENPHIIDKHQ IWVGVVPRGP DGAQLSSAFD RRFSEECLSS
     LGKALGNIAR VVPYGLLIFF PSYPVMEKSL EFWRARDLAR KMEALKPLFV EPRSKGSFSE
     TISAYYARVA APGSTGATFL AVCRGKASEG LDFSDTNGRG VIVTGLPYPP RMDPRVVLKM
     QFLDEMKGQG GAGGQFLSGQ EWYRQQASRA VNQAIGRVIR HRQDYGAVFL CDHRFAFADA
     RAQLPSWVRP HVRVYDNFGH VIRDVAQFFR VAERTMPAPA PRATAPSVRG EDAVSEAKSP
     GPFFSTRKAK SLDLHVPSLK QRSSGSPAAG DPESSLCVEY EQEPVPARQR PRGLLAALEH
     SEQRAGSPGE EQAHSCSTLS LLSEKRPAEE PRGGRKKIRL VSHPEEPVAG AQTDRAKLFM
     VAVKQELSQA NFATFTQALQ DYKGSDDFAA LAACLGPLFA EDPKKHNLLQ GFYQFVRPHH
     KQQFEEVCIQ LTGRGCGYRP EHSIPRRQRA QPVLDPTGRT APDPKLTVST AAAQQLDPQE
     HLNQGRPHLS PRPPPTGDPG SQPQWGSGVP RAGKQGQHAV SAYLADARRA LGSAGCSQLL
     AALTAYKQDD DLDKVLAVLA ALTTAKPEDF PLLHRFSMFV RPHHKQRFSQ TCTDLTGRPY
     PGMEPPGPQE ERLAVPPVLT HRAPQPGPSR SEKTGKTQSK ISSFLRQRPA GTVGAGGEDA
     GPSQSSGPPH GPAASEWGL
//
